However, pre-clinical studies show that in some cancers, an interaction of LSD1 with tran-scription factors, acting independently of the enzyme activity, is crucial for prolif-eration, and inhibitors of these interactions are under development (see Table 2 and Figure 3). Here, KDM1A is linked to cancer.